ADSOL RED CELL PRESERVATION

Manufacturer
Fenwal, Inc. | Fenwal International, Inc.
Effective date
2022-06-03
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:41:50

Label at a glance#

ProductADSOL RED CELL PRESERVATION
Active ingredientTRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE, ANHYDROUS CITRIC ACID, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM CHLORIDE, MANNITOL, ADENINE
Label structure2 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Blood-Pack Unit with an Integral Fenwal Bioflex RC Leukocyte Reduction Filter Using CPD/Adsol Red Cell Preservation Solution for Whole Blood Collection and Filtration of Red Blood Cells and Fenwal HighFlo Needle

Contains Sample Diversion System for the collection of unanticoagulated whole blood samples for laboratory testing.

Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat.

Definition of “Controlled Room Temperature”:

“A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25° C (68° to 77° F); that results in a mean kinetic temperature calculated to be not more than 25° C; and that allows for excursions between 15° C and 30° C (59° and 86° F) that are experienced in pharmacies, hospitals, and warehouses. Provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40°C are permitted as long as they do not exceed 24 hours ... The mean kinetic temperature is a calculated value that may be used as an isothermal storage temperature that simulates the non isothermal effects of storage temperature variations.”

Reference: United States Pharmacopeia, General Notices. United States Pharmacopeial Convention, Inc.

12601 Twinbrook Parkway, Rockville, MD.

Integral filter unit intended for leukocyte reduction of AS-1 red blood cells:

• At ambient temperature up to 8 hours after blood collection.

• At refrigerated temperature (1° to 6° C) up to 3 days after blood collection if AS-1 red blood cells are prepared within 3 days after whole blood collection.

The leukocyte reduced red blood cells may then be stored for up to 42 days after collection.

Instructions for Use

Collection Procedure:

Use aseptic technique.

Notes:

  • If sample diversion system is not used, donor samples may be collected using an alternative method following standard procedures.
  • Nominal tubing dimensions of product are 0.118" inner diameter x 0.025" wall thickness.

Precautions:

  • Upon removal of Blood-Pack unit from the clear plastic overwrap, visually inspect the unit.
  • Do not use the product if the in-line cannula is broken and/or anticoagulant is present in the sample pouch or in the tubing from the in-line cannula to the sample pouch and donor needle (see Figure 1). Note that condensation in the empty tubing of the Blood-Pack unit is expected as a result of the sterilization process.
  • Do not use unless the solutions are clear.
  • Identify Blood-Pack unit using appropriate donor identification system.
  • Adjust donor scale to desired collection weight and position primary container on the donor scale as far as possible below donor arm.
  • Clamp donor tubing between Fenwal HighFlo1 needle and Y-junction with a clamp. (This step may be performed prior to step 1 or 2.)
  • Visually inspect the tubing from the in-line cannula to the sample pouch and donor needle, as well as the sample pouch to reconfirm that there is no anticoagulant present.

Note: Ensure that the sample pouch remains below the donor’s arm.

  1. Following blood center procedures, apply pressure to donor’s arm and disinfect site of venipuncture.
  2. Remove needle cover per instructions below:
    1. Holding the hub and cover near the tamper-evident seal, twist cover and hub in opposite directions to break seal.
    2. Remove needle cover, being careful not to drag the cover across the needle point.
  3. Following blood center procedures, perform venipuncture, appropriately secure donor needle and/or tubing and release clamp on donor tubing. When good blood flow is established, stabilize the front of the needle guard to arm with tape (see Figure 2).
  4. Allow the sample pouch to fill with blood according to center procedure. Monitor blood flow into sample pouch.

Notes:

  • The sample pouch contains an average fill volume of approximately 53 mL with a maximum fill volume of approximately 60 mL when filled to capacity.
  • If less blood sample volume is required, the flow to the sample pouch may be stopped prior to completely filling the pouch. For example, in order to target a fill volume of approximately 40 mL, fill to the level indicated by the arrows in Figure 1. Ensure the pouch is hanging vertically.
  • The tube leading from the Y-junction to the sample pouch contains an additional volume of approximately 2 mL.

Precautions:

  • Do not elevate or squeeze the sample pouch as this could cause blood to backflow from the sample
  • pouch into the collection system.
  • Once the sample pouch is filled to desired volume, complete steps 9 – 17 within approximately 4 minutes to avoid possible clot formation in the tubing and/or sample pouch.
  • Close the blue clamp on tubing between the Y-junction and the sample pouch.
  • Break the in-line cannula below the Y-junction in the donor tubing to the primary container allowing blood collection to proceed. To completely break the in-line cannula, grasp with both hands. Snap it at a 90° angle in one direction, and then bend it at a 90° angle in the opposite direction. Ensure the in-line cannula is completely broken and that the blood flows freely to the primary container.

Precaution: Failure to break the in-line cannula completely may result in restricted blood flow.

  1. Mix blood and anticoagulant in the primary container immediately, at several intervals during collection, and immediately after collection.
  2. Following blood center procedures, hermetically seal the tubing between the sampling site and the Y-junction to maintain sterility of the blood collection system prior to removing blood samples.

Warning:

  • Do not proceed with the remaining steps until the tubing leading to the sample pouch is hermetically sealed between the sampling site and the Y-junction. To maintain the whole blood collection container as a closed system, the tubing between the sample pouch and Y-junction must be hermetically sealed prior to inserting the access device into the sampling site. Failure to do so may lead to contamination of the whole blood collection.
  • To collect samples, insert the access device by pushing firmly into the sampling site until the membrane seal is penetrated.

Note: If the access device is assembled such that the outer barrel is screwed onto the Luer, make sure to rotate clockwise upon insertion to avoid barrel detaching from Luer.

  1. Open the cap on the access device (if applicable). Hold access device so that the sample pouch hangs down.
  2. Directly align the vacuum sample tube with the internal needle in the access device. Insert vacuum sample tube into device until the stopper is punctured.
  3. Allow vacuum sample tube to fill with blood then remove from the access device.
  4. Repeat steps 15 and 16 until the desired number of vacuum sample tubes have been filled.

Notes:

  • If the access device needs to be replaced, clamp the tubing between the sampling site and the sample pouch.Then grasp base of sampling site with one hand and pull the access device out with the other hand. Firmly insert the new access device. Remove clamp and continue sampling.
  • If the access device is assembled such that the outer barrel is screwed onto the Luer, make sure to rotate clockwise upon removal to avoid barrel detaching from Luer.
  • The access device can only be replaced one time.

Precaution: When replacing access device, be careful to avoid contact with any blood droplets on the Luer or sampling site. Discard used access device appropriately.

  1. Collect the appropriate volume based on Blood-Pack unit used.

Note: The volume of anticoagulant is sufficient for the blood collection indicated on Blood-Pack unit ± 10%.

Precaution: Once the desired blood volume is collected, complete steps 19 – 23 within approximately

4 minutes to avoid possible clot formation in the tubing.

  1. Release pressure on donor’s arm. If appropriate, apply clamp to donor tubing between needle and the Y-junction.
  2. Hermetically seal donor tubing between the in-line cannula and the primary container.
  3. Withdrawal of Needle (see Figure 3).

Precaution: The needle guard must be held stationary while the needle is withdrawn into it.

    • Place folded sterile gauze over puncture site and hold in place with finger tip without exerting pressure.
    • Hold sides of needle guard near the front, between the index finger and thumb. Pull the hub back smoothly until the needle is completely enclosed and securely locked into the needle guard.
    • Confirm the needle is completely enclosed and securely locked into the needle guard.
  • Remove and discard the sample diversion system and needle guard into an appropriate biohazardous waste container following established procedures. If donor tubing is also to be discarded, hermetically seal donor tubing directly above the primary container and remove.

Note: Step 23 may be performed prior to step 22 if desired.

  1. If the donor tubing is not hermetically sealed directly above the primary container, then strip the blood from the remaining donor tubing into the primary container and mix. If desired, allow tubing to refill.

Component Preparation:

Notes:

  • If a platelet concentrate is to be prepared, it should be separated within 8 hours after blood collection.
  • Fresh frozen plasma should be separated from the red blood cells and placed in the freezer at -18° C or colder within 8 hours after blood collection.
  • Adsol red cell preservation solution should be added to the red blood cells immediately after the removal of plasma. Preparation of AS-1 red blood cells may vary depending on processing option selected:
  • Within 8 hours of blood collection if whole blood is held at ambient temperature.
  • Within 3 days of blood collection if whole blood is refrigerated.
  • At the appropriate time, prepare the Blood-Pack unit with integral filter for centrifugation.
  • Thoroughly mix the primary container end over end.
  • Load the Blood-Pack unit into a centrifuge cup per the instructions on page 3 or 4.

    Page 3 describes Option A, the method of centrifuge cup loading when using standard oval centrifuge cups. Page4 describes Option B, the method of centrifuge cup loading when using large oval centrifuge cups. This method differs from Option A in steps 7 – 9 only and shows the use of a blood bag insert to help fill extra space inside the cup.

Notes:

  • This guide is one method for centrifuge cup loading and applies to all Bioflex RC configurations. The specific stacking order and methods may vary depending on the workstation setup, centrifuge equipment, and your facilities Standard Operating Procedures.
  • It is important to pack the filter properly in the centrifugation cup to avoid damage to the filter during centrifugation.
  • Do not place the filter in the lower half of the centrifuge cup. See step 3 on page 3 or 4 for proper placement of filter.
  • Do not press directly on the cannulae while performing any of the cup loading steps as this may cause preactivation of the cannulae.
  • After loading the Blood-Pack unit into the centrifuge cup, perform centrifugation according to center procedures.
  • Following centrifugation, remove containers from the centrifuge cup taking care not to disturb the red blood cell/plasma interface.
  • Place primary container in a plasma extractor and apply pressure. Clamp off tubing above the filter to prevent plasma flow into filter during plasma transfer. If applicable, clamp off tubing below Y-Junction leading to secondary Transfer Pack container not to be filled with plasma. Open the cannula on the top of the primary container to transfer plasma into the empty Transfer Pack container.
  • When the desired amount of plasma has been removed, clamp the tubing between the plasma container and the Y-connector closest to the plasma container and release pressure on the primary container. Seal and remove satellite container(s).
  • Position the Adsol red cell preservation solution container ensuring that the primary container remains below the level of the filter during prime. Open the cannula on the Adsol solution container and remove the clamp between the primary container and the filter. Transfer the Adsol through the filter into the primary container. Clamp the tubing between the filter and the primary container after prime is complete.
  • Mix the Adsol red cell preservation solution and red cells thoroughly.

Filtration Procedure:

Precaution: Red blood cell products collected from certain donors may have extended filtration times

and the potential for ineffective filtration and leukoreduction.

  1. Mix unfiltered AS-1 red blood cells thoroughly. Invert the unfiltered AS-1 red blood cells and hang the filter set such that the filter remains vertical. Filtration may be performed from 165 cm up to full length. To achieve maximum flow rate, allow the set to hang to full length. The storage container must remain below the level of the filter during filtration.
  2. Filtration must be initiated up to 8 hours after collection at ambient condition or up to 3 days at refrigerated temperature.
  3. Inspect all tubing to ensure it hangs freely without kinks.
  4. Remove the clamp above the filter to start filtration.

Note: Manual or mechanical pressure should not be used to increase the flow rate through the filter. Tubing below the filter should not be stripped at any time during the filtration process.

Note: If filtration of red cells is initiated at ambient temperature, the filtration process can be completed at either ambient or refrigerated temperature prior to storing the red cells between 1 and 6° C. However, for optimal filtration time, it is recommended to complete the filtration at ambient temperature.

  1. When filtration is complete, air can be observed in the inlet side of the filter. Hermetically seal and detach the tubing below the filter.
  2. Make segments from the post filter tubing and leave segments attached to the filtered red cell storage container. (QC samples may be prepared by thoroughly mixing the filtered red cells and stripping this tubing prior to sealing the segments.)
  3. Store the AS-1 red blood cells, leukocytes reduced between 1 and 6° C.
  4. Infuse the red cells within 42 days of collection.
  5. Quality control should be per FDA “Guidance for Industry – Pre- Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion”, current issue.

Warning: Failure to achieve closed system processing conditions negates the extended storage claim

and the red blood cell product must be transfused within 24 hours.

1787dfuimage1
1787dfuimage1
1787symbols
1787symbols
1787image2
1787image2
1787image3
1787image3

1 Van der Meer, P.F., & de Korte, D. “Increase of blood donation speed by optimizing the needle-to-tubing connection: an application of donation software.” Vox Sanguinis 2009, 97:21-25.

Fresenius Kabi AG

61346 Bad Homburg / Germany

www.fresenius-kabi.com

1-800-933-6925

©2021 Fresenius Kabi AG. All rights reserved.

All trademarks referred to are property of their respective owners.

472315541 [A] 2021/09

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

To Open Tear Across at Notch

10x

Rx only

Code 6R1790

Fresenius Kabi

Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) Blood-Pack Unit; Transfer-Pack Container with Adsol Red Cell Preservation Solution; Integral Fenwal Bioflex RC Red Cell Leukocyte Reduction Filter

For the Collection and Processing of 500 mL Blood, Sample Diversion System, 16 ga. Ultra Thin Wall

Fenwal HighFlo Needle

Store at Controlled Room Temperature.

Protect from freezing. Avoid excessive heat.

Each unit consists of a primary container with 70 mL of CPD solution containing 1.84 g Sodium

Citrate (dihydrate) USP, 1.78 g Dextrose (monohydrate) USP, 209 mg Citric Acid (anhydrous) USP, 155 mg Monobasic Sodium Phosphate (monohydrate) USP, pH may have been adjusted with sodium hydroxide; three empty 600 mL Transfer-Pack containers; one integral Fenwal Bioflex RC Red Cell Leukocyte reduction filter and one 600 mL Transfer-Pack container with 110 mL of Adsol Red Cell Preservation Solution containing 2.42 g Dextrose (monohydrate) USP, 990 mg Sodium Chloride USP, 825 mg Mannitol USP, 30 mg Adenine USP for the storage of AS-1 red blood cells, leukocytes reduced.

  • Open pouch by tearing across at notch.
  • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth.
  • Unused units in open foil pouch may be kept up to 30 days by folding and securing open end of foil pouch to prevent possible loss of moisture, provided:
  • Units are not removed from foil pouch, or
  • Unused units removed from foil pouch are returned to the foil pouch within 12 hours. Units may be removed from the pouch and returned only once.
  • Units removed from the foil pouch (that are not returned to the pouch within 12 hours) must be used within 4 days (96 hours). Units out of the foil pouch for longer than 96 hours must be discarded.
1787lblsymbols
1787lblsymbols

Manufacturer

Fresenius Kabi AG

61346 Bad Homburg / Germany

www.fresenius-kabi.com

Manufacturing facility /

Manufactured by

Fenwal International, Inc.

Road 357, KM 0.8

Maricao, Puerto Rico 00606

Made in US

472614282 REV: A


6R1790lbl
6R1790lbl

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813
MANNITOL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
SODIUM CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0942-6518-01ADSOL RED CELL PRESERVATION1 in 1 KITKIT12
0942-6518-02ADSOL RED CELL PRESERVATION9 in 1 POUCHKIT92
0942-6518-03ADSOL RED CELL PRESERVATION2 in 1 CARTONKIT22

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0942-6518ADSOL RED CELL PRESERVATION (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION) KIT [FENWAL, INC.]2Current NDC, Legacy NDC, 3 package rows20220604_8bb18310-c873-4fd7-adc0-cee3be1068ea.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0942-65180942-6518-01, 0942-6518-02, 0942-6518-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADSOL RED CELL PRESERVATIONANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATIONFenwal, Inc.8bb18310-c873-4fd7-adc0-cee3be1068ea2022-06-03Exact identifier
ndc (package): 0942-6518-01
ndc (package): 0942-6518-02
ndc (package): 0942-6518-03
ndc (product): 0942-6518
ndc11 (package): 00942651803
ndc11 (package): 00942651801
ndc11 (package): 00942651802
spl id: 9365e352-13a0-43fc-bb9a-5ff93de28464
spl set id: 8bb18310-c873-4fd7-adc0-cee3be1068ea

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.